Acute Type A Aortic Dissection
Conditions
Brief summary
This prospective study investigated the comparison of effectiveness of antegrade cerebral perfusion (ACP) and retrograde cerebral perfusion (RCP) in providing cerebral protection during the surgical treatment of acute Type A aortic dissection (TAAD). Acute type A aortic dissection presents an aortic tear at its ascending portion, posing considerable risk with high morbidity and mortality incidence, especially from neurological insults. In total, 116 patients with acute type A aortic dissection were randomly assigned to undergo surgical intervention with either ACP through axillary artery cannulation or RCP through superior vena cava cannula placed during deep hypothermic circulatory arrest. Primary objectives focused on measuring and comparing the postoperative neurological complication rates associated with transient neurological deficits (TND) and permanent neurological deficits (PND). Secondary outcomes of interest included the duration of mechanical ventilation, length of stay in the ICU and hospital, and mortality.
Interventions
In antegrade cerebral perfusion (ACP), patients underwent cannulation of the right axillary artery using an interposition Dacron graft (7 mm) connected to a cardiopulmonary bypass (CPB) circuit. During surgery, ACP delivered oxygenated blood flow directly into the brain arteries to maintain cerebral protection during the period of deep hypothermic circulatory arrest (DHCA), enabling the surgical team to perform the distal aortic anastomosis safely.
In retrograde cerebral perfusion (RCP), cannulation of the superior vena cava (SVC) was performed to deliver blood flow in reverse direction during deep hypothermic circulatory arrest (DHCA). This method aimed to provide cerebral protection by supporting cerebral metabolism during the surgical repair of acute Type A aortic dissection.
Sponsors
Study design
Eligibility
Inclusion criteria
\- Patients diagnosed with acute type A aortic dissection (TAAD).
Exclusion criteria
* Hemodynamic instability. * Known ischemic heart disease (IHD). * History of cerebrovascular stroke. * Heart failure. * Renal or hepatic impairment. * Rheumatic heart disease. * Previous history of radiotherapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Neurological Complications (Transient and Permanent Neurological Deficits) | Postoperative assessment period (up to 30 days after surgery) | Comparison of the incidence of neurological complications, including transient neurological deficits (temporary postoperative mental status changes or neurological dysfunction resolving within 24 hours) and permanent neurological deficits (lasting neurological impairments such as stroke, paralysis, coma, or death). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative Mortality Rate | 30 days post-surgery | Comparison of mortality rates within 30 days following surgical intervention between the two perfusion groups (ACP vs. RCP). |
Countries
Egypt